The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Statins for the primary prevention of cardiovascular disease
Open accessAbstract
How safe are they?Use of statins by low risk patients has been criticised on the grounds that their benefits do not outweigh their harms 12 and debated. 13 14However, all cause mortality in people taking statins with no pre-existing cardiovascular disease is reduced (table⇓), indicating that any unintended life threatening effects are outweighed by their beneficial impact on cardiovascular disease, although this evidence is not strong. 15Earlier concerns about cancer risk are unfounded. 16However, other unintended effects
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Self-citationThe safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
Genest, J., McPherson, R., Frohlich, J., Anderson, T., Campbell, N., Carpentier, A., Couture, P., Dufour, R., Fodor, G., Francis, G. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70715-9 · Cited by 768
Statin effects beyond lipid lowering—are they clinically relevant?
Bonetti, P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00419-0 · Cited by 527
Hippisley-Cox, J., & Coupland, C. (2010) · BMJ · doi:10.1136/bmj.c2197 · Cited by 512
Ray, K. K. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.182 · Cited by 446
Cholesterol Treatment Trialists' (CTT) Collaboration (2012) · PLoS ONE · doi:10.1371/journal.pone.0029849 · Cited by 351
Mills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., & Briel, M. (2011) · QJM · doi:10.1093/qjmed/hcq165 · Cited by 338
The lipid and non-lipid effects of statins
Wierzbicki, A. S., Poston, R., & Ferro, A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00055-x · Cited by 253
Smeeth, L., Douglas, I., Hall, A. J., Hubbard, R., & Evans, S. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03308.x · Cited by 234
The Merck Manual of Diagnosis and Therapy.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-813_5 · Cited by 141
Weighing the benefits of high-dose simvastatin against the risk of myopathy
Egan, A., & Colman, E. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1106689 · Cited by 113
Toth, P. P. (2012) · Yearbook of Medicine · doi:10.1016/s0084-3873(12)00318-5 · Cited by 96
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration
Wardle, J., Armitage, J., Collins, R., Wallendszus, K., KEECH, A. C., & Lawson, A. (1996) · BMJ · doi:10.1136/bmj.313.7049.75 · Cited by 90
Toth, P. P. (2012) · Yearbook of Endocrinology · doi:10.1016/j.yend.2012.05.044 · Cited by 70
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Gersh, B. J. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00283-5 · Cited by 37
Should people at low risk of cardiovascular disease take a statin?
(2014) · BDJ · doi:10.1038/sj.bdj.2014.375 · Cited by 24
Effect of Rosuvastatin on Fatigue in Patients With Heart Failure
Moreno, A. C. P., Jhund, P. S., Preiss, D., KJEKSHUS, J. K., & McMurray, J. J. V. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.004 · Cited by 14
Is intensive LDL-cholesterol lowering beneficial and safe?
Cheung, B. M. Y., & Lam, K. S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61545-0 · Cited by 13
Improving vascular health: are pills the answer?
Smeeth, L. L., & Hemingway, H. (2012) · BMJ · doi:10.1136/bmj.e3802 · Cited by 7
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Metadata
- Authors
- Ebrahim, S., Taylor, F. C., & Brindle, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-01-27
- Volume
- 348
- Issue
- jan27 4
- Pages
- g280-g280
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W4297752226
- Cited by
- 333
- References
- 23
- FWCI
- 44.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.